Hsbc Holdings PLC Bristol Myers Squibb CO Call Options Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $7.86 Million - $10.3 Million	198,300 Added 116.65%	368,300 $19.1 Million
Q2 2024 Aug 12, 2024	BUY	$40.25 - $52.99 $6.84 Million - $9.01 Million	170,000 New	170,000 $7.06 Million
Q4 2023 Feb 12, 2024	BUY	$48.48 - $57.85 $489,647 - $584,285	10,100 Added 25.25%	50,100 $2.57 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $7.27 Million - $8.12 Million	-125,500 Reduced 75.83%	40,000 $2.32 Million
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $7.47 Million - $8.3 Million	117,300 Added 243.36%	165,500 $10.6 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $8.91 Million - $10.1 Million	-135,600 Reduced 73.78%	48,200 $3.34 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $4.68 Million - $5.55 Million	68,400 Added 59.27%	183,800 $13.2 Million
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $2.54 Million - $2.8 Million	35,000 Added 43.53%	115,400 $8.93 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $4.77 Million - $5.72 Million	77,600 Added 2771.43%	80,400 $5.9 Million
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $100,878 - $113,457	-1,700 Reduced 37.78%	2,800 $176,000
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $301,510 - $352,495	-5,500 Reduced 55.0%	4,500 $264,000
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $5.36 Million - $7 Million	-109,000 Reduced 91.6%	10,000 $639,000
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $3.95 Million - $4.69 Million	92,400 Added 347.37%	119,000 $6.03 Million
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $530,978 - $587,146	11,900 Added 80.95%	26,600 $1.21 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $3.87 Million - $4.61 Million	-85,700 Reduced 85.36%	14,700 $701,000
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $4.93 Million - $6.39 Million	-101,100 Reduced 50.17%	100,400 $5.22 Million
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $6.24 Million - $7.04 Million	113,100 Added 127.94%	201,500 $12.5 Million
Q2 2018 Aug 10, 2018	SELL	$50.53 - $62.98 $6.09 Million - $7.59 Million	-120,500 Reduced 57.68%	88,400 $4.89 Million
Q1 2018 May 11, 2018	BUY	$59.92 - $68.98 $3.18 Million - $3.66 Million	53,100 Added 34.08%	208,900 $13.2 Million
Q3 2017 Nov 14, 2017	SELL	$55.23 - $63.74 $12 Million - $13.8 Million	-216,500 Reduced 58.15%	155,800 $9.93 Million
Q2 2017 Aug 14, 2017	BUY	N/A	372,300	372,300 $20.7 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.34 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.47 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.59 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.59 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account